title: Salmonella-mediated gene therapy in experimental colitis in mice.
abstract: Bacterial gene therapy - bactofection is a simple and effective method to deliver plasmid DNA into target tissue. We hypothesize that oral in vivo bactofection can be an interesting approach to influence the course of inflammatory bowel diseases. The aim of this study was to prove the effects of antioxidative and anti-inflammatory bactofection in dextran sulfate sodium (DSS)-treated mice. Attenuated bacteria Salmonella Typhimurium SL7207 carrying plasmids with genes encoding Cu-Zn superoxide dismutase and an N-terminal deletion mutant of monocyte chemoattractant protein-1 were prepared. Male Balb/c mice had ad libitum access to 1% DSS solution in drinking water during 10 days (mild model of colitis). The animals were daily fed with 200 Mio bacteria via gastric gavage during the experiment. Fecal consistency, clinical status, food and water intake were monitored. After 10 days samples were taken and markers of oxidative stress and inflammatory cytokine levels were measured. Colonic tissue was scored histologically by a blinded investigator. DSS treatment significantly increased the levels of inflammatory cytokines and malondialdehyde as a marker of lipoperoxidation in the colon. Anti-inflammatory gene therapy improved the total antioxidative capacity. In comparison with the untreated group, bacterial gene therapy lowered the histological colitis score. Salmonella-mediated antioxidative and anti-inflammatory gene therapy alleviated colitis in mice. The effect seems to be mediated by increased antioxidative status. Further studies will show whether recombinant probiotics expressing therapeutic gene might be used for the therapy of inflammatory bowel diseases.
authors.affiliation: Insitute of Molecular Biomedicine, Comenius University, Bratislava, Slovak Republic.
authors.forename: Roland
authors.initials: R
authors.lastname: Palffy
authors.forename: Roman
authors.initials: R
authors.lastname: Gardlik
authors.forename: Michal
authors.initials: M
authors.lastname: Behuliak
authors.forename: Peter
authors.initials: P
authors.lastname: Jani
authors.forename: Denisa
authors.initials: D
authors.lastname: Balakova
authors.forename: Ludevit
authors.initials: L
authors.lastname: Kadasi
authors.forename: Jan
authors.initials: J
authors.lastname: Turna
authors.forename: Peter
authors.initials: P
authors.lastname: Celec
mesh_terms: D000818:Animals; D018932:Chemokine CCL2 / Q000235:genetics* / Q000276:immunology; D003092:Colitis / Q000139:chemically induced* / Q000628:therapy*; D003106:Colon / Q000473:pathology; D016264:Dextran Sulfate / Q000633:toxicity; D004195:Disease Models, Animal; D015316:Genetic Therapy / Q000379:methods*; D006651:Histocytochemistry; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D012486:Salmonella typhimurium / Q000235:genetics* / Q000378:metabolism; D013482:Superoxide Dismutase / Q000235:genetics* / Q000378:metabolism
chemical_list: D018932:Chemokine CCL2; D016264:Dextran Sulfate; D013482:Superoxide Dismutase